Testosterone Support
Testosterone Support, licence 80148292: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- TestoBoost, Testosterone Booster
- Licence holder
- Kasha Nutrition Inc.
- NPN or DIN-HM
- 80148292
- Status
- Active licence
- Licence date
- 1 April 2026
- Revision date
- 27 August 2026
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Tribulus terrestris L.: Les parties de plantes doivent être cuites
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Lepidium meyenii Walp.: L'absence d'alcaloïdes doit être démontrée par des rapports d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Mucuna pruriens Source : Mucuna pruriens - graine Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 500 mg | 25.0 mg | Not calculated |
| Eurycoma longifolia Extract : Matériel brut sec Extraction ratio : 50:1 Dry plant equivalent : 5000 mg Potency : 1.5 % Eurycomanone | 100.0 mg | Not calculated |
| Eurycoma longifolia Potency : 40.0 % Glycosaponins | Not specified | Not calculated |
| Tribulus terrestris Source : Tribulus terrestris - Fruit Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 2000 mg | 200.0 mg | Not calculated |
| Panax ginseng Source : Panax ginseng - racine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 200 mg | 50.0 mg | Not calculated |
| Lepidium meyenii Source : Lepidium meyenii - racine Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 1000 mg | 50.0 mg | Not calculated |
| 3,3'-Diindolylméthane Source : 3,3'-diindolylméthane | 30.0 mg | Not calculated |
| Epimedium sagittatum Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 500 mg Potency : 10.0 % Icariin | 25.0 mg | Not calculated |
| Ginkgo biloba Source : Ginkgo biloba - feuille Extract : Matériel brut sec Extraction ratio : 30:1 Dry plant equivalent : 1500 mg Potency : 24.0 % Flavonoid glycosides | 50.0 mg | Not calculated |
| Ginkgo biloba Source : Ginkgo biloba - feuille Potency : 6.0 % Terpene lactones | Not specified | Not calculated |
| Eleutherococcus senticosus Source : Eleutherococcus senticosus - racine | 30.0 mg | Not calculated |
Non-medicinal ingredients
Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Hommes | minimum: 19.0 Année(s) | 1.0 Capsule | 3.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to support emotional aspects of sexual health. Helps to enhance cognitive function in adults. Helps to enhance memory in adults. Helps to support peripheral circulation. Helps to support/promote healthy estrogen metabolism/balance. Source of (an) antioxidant(s)/Provides (an) antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Helps promote testosterone production in men. Supports testosterone production in men. Panax Ginseng is used in Herbal Medicine as supportive therapy for the promotion of healthy glucose levels. Panax Ginseng is used in Herbal Medicine to help(s) enhance physical capacity/performance (in cases of physical stress). Panax Ginseng is used in Herbal Medicine to help(s) support cognitive function and/or reduce mental fatigue (in cases of mental stress).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80148292
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.